Pashkina E, Blinova E, Bykova M, Aktanova A, Denisova V
Cells. 2025; 13(24.
PMID: 39768148
PMC: 11675046.
DOI: 10.3390/cells13242056.
Rahim U, Iftikhar R, Ghafoor T, Khan H, Siddiq A, Tariq H
Cureus. 2024; 16(8):e67566.
PMID: 39310495
PMC: 11416716.
DOI: 10.7759/cureus.67566.
Martinez-Lopez J, Lopez-Munoz N, Chari A, Dorado S, Barrio S, Arora S
Blood Cancer J. 2024; 14(1):131.
PMID: 39112458
PMC: 11306767.
DOI: 10.1038/s41408-024-01102-x.
Cordon L, Chorao P, Martin-Herreros B, Montoro J, Balaguer A, Guerreiro M
Ann Hematol. 2024; 103(7):2475-2484.
PMID: 38634914
DOI: 10.1007/s00277-024-05758-0.
Castiello M, Brandas C, Ferrari S, Porcellini S, Sacchetti N, Canarutto D
Sci Transl Med. 2024; 16(733):eadh8162.
PMID: 38324638
PMC: 11149094.
DOI: 10.1126/scitranslmed.adh8162.
Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying hypomorphic mutations.
Castiello M, Di Verniere M, Draghici E, Fontana E, Penna S, Sereni L
Front Immunol. 2023; 14:1268620.
PMID: 38022635
PMC: 10679457.
DOI: 10.3389/fimmu.2023.1268620.
Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients.
Thole L, Toth L, Pross V, Siegle J, Stahl C, Hermsdorf G
Front Immunol. 2023; 14:1239519.
PMID: 37942315
PMC: 10628529.
DOI: 10.3389/fimmu.2023.1239519.
Applying Rituximab During the Conditioning Regimen Prevents Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplant in a Children's Cohort: A Retrospective Case-Control Study.
Ruan Y, Chen L, Luo T, Xie D, Cao W, Liu X
Infect Dis Ther. 2023; 12(8):2071-2086.
PMID: 37470925
PMC: 10505124.
DOI: 10.1007/s40121-023-00841-x.
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Takahashi T, Al-Kofahi M, Jaber M, Bratrude B, Betz K, Suessmuth Y
Blood. 2023; 142(8):700-710.
PMID: 37319437
PMC: 10797507.
DOI: 10.1182/blood.2023020035.
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD.
Raman D, Chene C, Nicco C, Jeljeli M, Eu J, Clement M
Biology (Basel). 2023; 12(5).
PMID: 37237461
PMC: 10215844.
DOI: 10.3390/biology12050647.
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities.
Chen Y, Li J, Xu L, Gaman M, Zou Z
World J Clin Cases. 2023; 11(2):268-291.
PMID: 36686358
PMC: 9850970.
DOI: 10.12998/wjcc.v11.i2.268.
Clinical Impact of Recipient-Derived Isoagglutinin Levels in ABO-Incompatible Hematopoietic Stem Cell Transplantation.
Nam M, Hur M, Kim H, Lee T, Lee G, Yoon S
J Clin Med. 2023; 12(2).
PMID: 36675387
PMC: 9866227.
DOI: 10.3390/jcm12020458.
Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation.
Wang H, Liu H, Zhou L, Wang D, Wang S, Liu Q
iScience. 2022; 25(10):105065.
PMID: 36147955
PMC: 9485910.
DOI: 10.1016/j.isci.2022.105065.
Immune Reconstitution in Pediatric Aplastic Anemia after Allogeneic Hematopoietic Stem-cell Transplantation.
Wang J, Yuan M, Zhu G, Wu R, Jia C, Wang B
Int J Med Sci. 2022; 19(5):821-828.
PMID: 35693743
PMC: 9149648.
DOI: 10.7150/ijms.70146.
Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach.
Wittenbecher F, Lesch S, Kolling S, Blau I, Vuong L, Borchert F
Front Immunol. 2022; 13:874499.
PMID: 35677053
PMC: 9168993.
DOI: 10.3389/fimmu.2022.874499.
Naïve B cells followed by aquaporin-4 antibodies characterise the onset of neuromyelitis optica: evidence from stem cell transplantation.
McNaughton P, Payne R, Michael S, Leahy T, Nicols A, Fower A
J Neurol Neurosurg Psychiatry. 2022; .
PMID: 35606107
PMC: 9606486.
DOI: 10.1136/jnnp-2022-328982.
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCT.
Fan Z, Han T, Zuo W, Zhao X, Chang Y, Lv M
Clin Exp Immunol. 2022; 208(3):332-339.
PMID: 35551362
PMC: 9226149.
DOI: 10.1093/cei/uxac047.
Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection.
Vigon L, Sanchez-Tornero A, Rodriguez-Mora S, Garcia-Perez J, De Lapuerta M, Perez-Lamas L
J Clin Med. 2022; 11(8).
PMID: 35456230
PMC: 9032116.
DOI: 10.3390/jcm11082137.
Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD.
Landwehr-Kenzel S, Muller-Jensen L, Kuehl J, Abou-El-Enein M, Hoffmann H, Muench S
Mol Ther. 2022; 30(6):2298-2314.
PMID: 35240319
PMC: 9171381.
DOI: 10.1016/j.ymthe.2022.02.025.
Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.
Yanir A, Schulz A, Lawitschka A, Nierkens S, Eyrich M
Front Pediatr. 2022; 9:786017.
PMID: 35087775
PMC: 8789272.
DOI: 10.3389/fped.2021.786017.